Medical News Today

New weight loss drug, taken once weekly, leads to 20% weight loss in trial

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight-loss drugs

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...

A Healthy Dose Of Competition Sends Weight-Loss Drug Prices Plummeting

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...

Making GLP-1 weight loss drugs cheaper isn't enough to address America's obesity problem. Here's why

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...
Public News Service on MSN

MS Medicaid patients face hurdles to getting weight loss drugs

By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Mississippi News Connection reporting for the ...
MiBolsilloColombia on MSN

Eli Lilly Hits $1 Trillion Value: How Weight-Loss Drugs Are Reshaping the Stock Market

Eli Lilly briefly became the first healthcare company to reach a $1 trillion market value, fueled by its blockbuster ...